Skip to main content
. 2020 Feb 10;10(7):3254–3262. doi: 10.7150/thno.39838

Figure 2.

Figure 2

Waterfall plots of the 4-month target lesions' percent of response after chemotherapy with PSA (A), RECIST 1.1 (B), and PERCIST 1.0 (C) response criteria. Of note, only 19 of the 47 patients enrolled had target lesions by RECIST 1.1 criteria and were evaluable. CR/CMR- complete response, SD/SMD- stable disease, PD/PMD- progressive disease, PR/PMR- partial response.